Literature DB >> 32492512

Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds.

Jie Yu1, Bingling Zhong1, Qingwen Xiao1, Lida Du2, Ying Hou1, Hong-Shuo Sun2, Jin-Jian Lu1, Xiuping Chen3.   

Abstract

Cell death plays a critical role in organism development and the pathogenesis of diseases. Necrosis is considered a non-programmed cell death in an extreme environment. Recent advances have provided solid evidence that necrosis could be programmed and quite a few types of programmed necrosis, such as necroptosis, ferroptosis, pyroptosis, paraptosis, mitochondrial permeability transition-driven necrosis, and oncosis, have been identified. The specific biomarkers, detailed signaling, and precise pathophysiological importance of programmed necrosis are yet to be clarified, but these forms of necrosis provide novel strategies for the treatment of various diseases, including cancer. Natural compounds are a unique source of lead compounds for the discovery of anti-cancer drugs. Natural compounds can induce both apoptosis and programmed necrosis. In this review, we summarized the recent progress of programmed necrosis and introduced their natural inducers. Noptosis, which is a novel type of programmed necrosis that is strictly dependent on NAD(P)H: quinone oxidoreductase 1-derived oxidative stress was proposed. Furthermore, the anti-cancer strategies that take advantage of programmed necrosis and the main concerns from the scientific community in this regard were discussed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Natural compounds; Programmed necrosis

Mesh:

Substances:

Year:  2020        PMID: 32492512     DOI: 10.1016/j.pharmthera.2020.107593

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  7 in total

Review 1.  Necrotic reshaping of the glioma microenvironment drives disease progression.

Authors:  Steven M Markwell; James L Ross; Cheryl L Olson; Daniel J Brat
Journal:  Acta Neuropathol       Date:  2022-01-17       Impact factor: 15.887

2.  Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress.

Authors:  Tingting Zhang; Chenxin Xu; Peisen Zheng; Xiaoxian Zhang; Chenyu Qiu; Fengjiao Wu; Jundixia Chen; Zhongxiang Xiao; Jiandong Zhu; Jingjing Zhang; Peng Zou; Daoyong Ni
Journal:  Oxid Med Cell Longev       Date:  2022-02-25       Impact factor: 6.543

3.  Construction of an algorithm based on oncosis-related LncRNAs comprising the molecular subtypes and a risk assessment model in lung adenocarcinoma.

Authors:  Hang Chen; Chongchang Zhou; Zeyang Hu; Menglu Sang; Saiqi Ni; Jiacheng Wu; Qiaoling Pan; Jingtao Tong; Kaitai Liu; Ni Li; Linwen Zhu; Guodong Xu
Journal:  J Clin Lab Anal       Date:  2022-04-27       Impact factor: 3.124

Review 4.  The Role of Programmed Necrosis in Colorectal Cancer.

Authors:  Yu-Qiang Yu; Reyes Gamez-Belmonte; Jay V Patankar; Eva Liebing; Christoph Becker
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

5.  Nitidine chloride induces caspase 3/GSDME-dependent pyroptosis by inhibting PI3K/Akt pathway in lung cancer.

Authors:  Fei Yu; Weidan Tan; Zhiquan Chen; Xiaoju Shen; Xiaoxiang Mo; Xiaocheng Mo; Jingchuan He; Zhihua Deng; Jie Wang; Zhuo Luo; Jie Yang
Journal:  Chin Med       Date:  2022-09-29       Impact factor: 4.546

Review 6.  Programmed cell death, redox imbalance, and cancer therapeutics.

Authors:  Xiaofeng Dai; Danjun Wang; Jianying Zhang
Journal:  Apoptosis       Date:  2021-07-08       Impact factor: 4.677

Review 7.  Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It.

Authors:  Jiayu Zou; Li Wang; Hailin Tang; Xiuxiu Liu; Fu Peng; Cheng Peng
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.